Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of triamcinolone acetonide suspension when used for visualization of structures in the back of the eye during eye surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Patients planning to undergo pars plana vitrectomy with good vision in the non-surgery eye.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Patients under 18.

• Patients with previous vitrectomy, elevated intraocular pressure (IOP) and/or history of ocular inflammatory disease.

• Other protocol-defined exclusion criteria may apply.